Aspen Neuroscience, Inc.

US$12.44As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:ASPEHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE —
Biotechnology
Beta (5Y) —
PE TTM —
TSR TTM —
Mkt cap US$361.7M
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
$14
10.42%
(74.33%)
Hold 5|7|5|5|5
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.25
0.27
0.27
0.29
12.47%
17.32%
14.23%
20.36%
Revenue$M
21.59
21.46
21.52
22.58
0.16%
(1.33%)
0.02%
7.80%
Peers (US$361.7M)
Cap (US$)
PE
357.0M
—
Capital
TTM
5Y
10Y
Leveragex
0.581
(0.937)
(0.792)
EBIT/Intx
10.17
0.109
0.090
Own earn%
59.87
22.43
26.86
Sh yield%
37.76
52.15
49.60
Owners
Insiders/Inst%
5.72
45.76
Short interest%
4.85
SBC / revenue%
3.39
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
1
Op margin range%
12–19
$1 testx
—
Incr. ROIC%
2